IMP
Process View
metanephric nephron morphogenesis
The process in which the anatomical structures of the metanephric nephron are generated and organized. A metanephric nephron is the functional unit of the metanephros.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "metanephric nephron morphogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGR3 | early growth response 3 | 0.953 | Human | |
| EGR1 | early growth response 1 | 0.916 | Human | |
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.890 | ||
| EGR2 | early growth response 2 | 0.770 | Human | |
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.696 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.580 | ||
| PKD1 | polycystic kidney disease 1 (autosomal dominant) | 0.573 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.495 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.339 | ||
| LAT | linker for activation of T cells | 0.290 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.284 | ||
| NKX2-1 | NK2 homeobox 1 | 0.243 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.223 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.192 | ||
| TCF4 | transcription factor 4 | 0.160 | ||
| IER2 | immediate early response 2 | 0.148 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.147 | ||
| FSTL1 | follistatin-like 1 | 0.141 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.122 | ||
| APC | adenomatous polyposis coli | 0.104 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.099 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.083 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.077 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.047 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.040 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.036 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.035 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.034 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.029 | ||
| CSNK1E | casein kinase 1, epsilon | 0.026 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.021 | ||
| AXIN1 | axin 1 | 0.020 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.018 | ||
| PKP4 | plakophilin 4 | 0.018 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.017 | ||
| TAOK1 | TAO kinase 1 | 0.016 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.015 | ||
| NGFR | nerve growth factor receptor | 0.015 | ||
| ERBB2IP | erbb2 interacting protein | 0.015 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.014 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.014 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.013 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.013 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.013 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.012 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.012 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.012 | ||
| JUP | junction plakoglobin | 0.012 | ||
| BMP2 | bone morphogenetic protein 2 | 0.011 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.010 | ||
| NPHP1 | nephronophthisis 1 (juvenile) | 0.010 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.010 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.010 | ||
| NOG | noggin | 0.010 | ||
| EGFR | epidermal growth factor receptor | 0.010 |